HIGHLIGHTS
- who: Wenxia Zhang from the Department of Medical Microbiology and Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China have published the paper: In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae, in the Journal: IPM
- what: The authors study the in vitro and in vivo bactericidal activity of administrated either alone or in combination with against KPC or NDM and explore a new clinical therapeutic regimen for infections induced by their resistant strains.
- how: Bacterial load testing results showed that there was no significant difference . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.